S
Sparx Therapeutics
Former Eli Lilly veteran Dr. Victor Wroblewski joins Sparx Therapeutics as a Senior VP and Head of Biology
About Sparx Therapeutics
Sparx Bio is a biotechnology company specializing in the development of advanced pharmaceutical innovations aimed at treating cancer and central nervous system (CNS) diseases. Utilizing cutting-edge technologies such as Big Data Aided Target Mining, Antibody Phage Display, and Hybridoma Antibody Discovery, Sparx Bio has built a robust pipeline of therapeutic candidates. The company’s proprietary platforms, LEMMAb™ and SMARTOP™, focus on creating bispecific and multispecific antibodies that are more soluble, less prone to aggregation, and easier to purify. These antibodies are designed to enhance the efficacy and safety of treatments by minimizing mismatches and optimizing yield. Additionally, Sparx Bio employs the SPARX MULCOM™ nanotechnology platform to deliver multiple drugs and biologics simultaneously, improving the effectiveness of combination therapies. Sparx Bio primarily serves pharmaceutical companies and research institutions, operating in the highly specialized market of biopharmaceuticals. The company generates revenue through partnerships, licensing agreements, and the sale of its proprietary technologies and therapeutic candidates.
Source: Dealroom company dataNews
Open roles
Sparx Therapeutics in the Mount Prospect ecosystem
The Sparx Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Sangel Capital
Highlight Capital- RFRotating Boulder Fund
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Sparx Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Sparx Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

